Microbot Medical Accounts Payable

Microbot Medical (MBOT) currently reports a accounts payable of $1.1M as of March 2026. That compares with $190K in the prior-year period — up 483.3% year over year. Use the charts on this page to explore Microbot Medical's accounts payable history and peer comparisons.

Microbot Medical's accounts payable increased from $190K to $1.1M — a 483.3% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Microbot Medical reported $1.1M in accounts payable as of March 2026. That compares with $190K in the prior-year period — up 483.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $1.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Microbot Medical, and consider following MBOT for alerts when major investors trade the stock.

Microbot Medical is classified in the Healthcare sector. On accounts payable, it currently shows $1.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MBOT with unrelated industries.